awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37827278-177C08C1-9D5B-446E-A19E-B66D3E783D45
Q37827278-177C08C1-9D5B-446E-A19E-B66D3E783D45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37827278-177C08C1-9D5B-446E-A19E-B66D3E783D45
Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia.
P2860
Q37827278-177C08C1-9D5B-446E-A19E-B66D3E783D45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37827278-177C08C1-9D5B-446E-A19E-B66D3E783D45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2b410b2cd199f1a7b84a579196e963be06cb7fc
P2860
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulatin